Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EMJ Oncology 12 [Supplement 2] 2024
March 2024
The BRAF V600E mutation occurs in 8–12% of patients with metastatic colorectal cancer, and is associated with poor prognosis. This…
Read more
March 2024
EMJ Oncology 12 [Supplement 2] 2024
The BRAF V600E mutation occurs in 8–12% of patients with metastatic colorectal cancer, and is associated with poor prognosis. This…
February 2024
EMJ Oncology 12 [Supplement 1] 2024
Following the presentation of practice-changing findings from RUBY and NRG-GY018 in patients with advanced or recurrent endometrial cancer at the SGO Annual Meeting in March 2023, data presented and published through the remainder of 2023 show that research in endometrial cancer continues at a pace.
January 2024
EMJ Dermatology 12 [Supplement 1] 2024
Melanoma of the skin is a common type of cancer that primarily affects younger patients. In Stage III melanoma, which does not involve…
December 2023
EMJ Oncology 11.1 2023
In our latest issue of EMJ Oncology, you will find a variety of peer-review articles on a range of topics, as well as exclusive interviews…
November 2023
EMJ Oncology 11 [Supplement 5] 2023
Incidence and mortality rates of endometrial cancer, the most common gynaecological cancer in high-income countries, are increasing…
October 2023
EMJ Oncology 11 [Supplement 4] 2023
Endometrial cancer is one of the most common gynaecological cancers in high-income countries, and the incidence is rising significantly…
October 2023
EMJ Oncology 11 [Supplement 3] 2023
Endometrial cancer is the most common gynaecological malignancy in developed countries, and often presents at an early stage. Paclitaxel…
October 2023
EMJ Oncology 11 [Supplement 2] 2023
As the medical community continues to explore and harness the potential of biosimilars, it is imperative to accumulate robust real-world…
Loading posts...
1
2
3
…
7
Next »